39
51
Growth Score
-9 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
98573
Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.
- Scott A. Smith: Chief Executive OfficerPast Role: BioAtla, President & Board Member
- Ayman Mokhtar: Regional President and Head of Middle East, Turkey and Levant
About the Company
They believe in healthcare as it should be empowering people worldwide to live healthier at every stage of life. Because of their unwavering belief that better access leads to better health, they leverage their best in class manufacturing and scientific expertise and proven commercial capabilities to bring quality medicines to patients when and
where they need them.
